• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

ixlayer Launches At-Home CBC Testing for Direct-to-Patient Biopharma Programs

by Syed Hamza Sohail 10/22/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– xlayer, the leading cloud-based platform powering an end-to-end direct-to-patient (DTP) healthcare experience, announced availability of a Complete Blood Count (CBC) test with at-home sample collection. This move supports biopharma partners who want to accelerate virtual care and reduce barriers to care for patients.

– Available through ixEngage, ixlayer’s DTP biopharma solution, biopharma companies can develop programs to include a CBC test, speciality and PCP telehealth consultations and prescription delivery. Top U.S. biopharma companies have already signed on to implement ixEngage’s remote CBC testing, with plans to make their programs publicly available as early as Q1 2025. 

Streamlining Patient-Centered Healthcare: ixEngage by ixlayer

ixlayer is the leading provider of cloud-based platforms, delivering a seamless, end-to-end direct-to-patient healthcare experience. The brand’s name symbolizes its core strengths: “i” represents a robust data and technology infrastructure, while “x” highlights its exceptional user experience. ixEngage, ixlayer’s proprietary platform, connects biopharma with patients and seamlessly integrates with all healthcare ecosystem partners. This technology accelerates diagnosis, supports optimal care, enhances operational efficiency, and improves health equity and outcomes for all.

Remote complete blood count (CBC) testing offers unparalleled accessibility to vital healthcare services traditionally available only in clinical settings. Using cutting-edge, easy-to-administer blood collection kits, patients can now collect samples from the comfort of their homes. The advanced technology within ixEngage ensures secure data transmission of lab results between patients and healthcare providers. Additionally, this digital care connection allows patients to receive timely feedback from physicians on CBC results and treatment options, driving patient-centered care initiatives.

This capability simplifies the prescribing process for essential medications, including biologics, by enabling remote CBC testing, a prerequisite for many treatments. It eliminates the need for in-person lab visits, allowing patients and physicians to access test results more quickly, which shortens the path to treatment. CBC testing is critical for diagnosing and managing conditions such as asthma, autoimmune diseases, cancer, chronic kidney disease, and heart disease. With ixEngage, biopharma can deliver a streamlined, data-driven patient journey that leads to faster treatment decisions and improved outcomes.

Approximately 70% of clinical decisions depend on lab testing, yet traditional methods result in 40% of blood lab prescriptions going unfulfilled. By removing bottlenecks in lab appointment scheduling, ixEngage’s remote CBC testing feature ensures that patients can more easily access essential diagnostics, reducing delays and enhancing the overall healthcare experience. A recent survey revealed that 83% of U.S. physicians believe at-home testing accelerates diagnoses and improves health outcomes, further underscoring the value of ixEngage’s integrated approach.

“With the ability to collect at-home CBC samples, patients will now have more convenient access to life-saving diagnostics, care and treatment,” said Dr. Bernard Esquivel, MD and PhD, Chief Medical Officer at ixlayer. “This advancement can allow physicians regular insight to a patient’s biomarkers resulting in personalized treatment plans, reducing hospitalizations, and ensuring timely interventions, particularly for those with limited access to healthcare facilities.” 

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

How eClinicalWorks Agentic AI Is Helping Revenue Cycle Leaders Improve Financial Performance

Most-Read

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

Innovaccer-CHIME 2030 Survey Reveals AI Will Automate Nearly Two-Thirds of Administrative Work and Do 3x the Work With the Same Staff

CB Insights’ 2026 Digital Health 50 Reveals How Agentic AI Is Becoming the Clinical Provider and Medication Access Engine

Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

M&A: Oura Acquires Counsel Health for $625M: Scaling Continuous Biometrics into On-Demand Medical Care

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

WittKieffer 2026 Healthcare CIO Survey: 82% Sit on Executive Teams, Yet Only 36% Have Formal Succession Plans

CVS Rebrands Health Services Segment, Launches Model for Retail Pharmacy Reimbursement

CVS Health Formalizes Tax-Free Split-Off to Carve Out CVS Pharmacy by 2028

SAMHSA and ONC Invest $20M in Behavioral Health IT Initiative

ONC Finalizes HTI-5 Deregulatory Rule to Cut $1.55B in Health IT Compliance and Accelerate FHIR APIs

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Redesign Health Merges with Sheba Medical Center’s ARC Global and Agrees to Acquire AVIA

Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Sword Acquires Headspace in All-Cash Deal Worth Up to $300M to Unify Physical and Mental AI Care

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

M&A: Francisco Partners to Acquire Weave in $650M Take-Private Deal

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Epic Launches One-Click Care Everywhere Diagnostic Image Exchange

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |